Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

PNC-27 FAQ: Your Questions Answered

The questions below are the ones that come up specifically about PNC-27, rather than general peptide questions that apply to everything.

Membranolytic fusion peptide (32 residues): p53-derived domain + membrane-penetrating leaderCellular Longevity

Overview

People ask how it targets cancer cells, what HDM-2 is, why it is in-vitro only, and whether it is a p53 peptide.

What PNC-27 actually is

A designed peptide studied only in the lab, in cell culture, for a striking trick: it latches onto HDM-2 on certain cancer cells and pokes holes in their outer membrane, breaking those cells apart while reportedly leaving healthy cells alone.

Supplied for laboratory research use only — not for human or animal use.

Research-grade PNC-27

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

PNC-27 — common questions

How is PNC-27 studied against cancer cells?

In cell culture it is examined for binding HDM-2 on the tumour-cell surface and forming membrane pores that cause those cells to break apart, with a reported sparing of normal cells. It is a strictly in-vitro research subject.

What is HDM-2?

HDM-2 (the human homolog of MDM2) is a regulator of p53. Its presence on the surface of certain cancer cells is the feature PNC-27 is studied to exploit in vitro.

Why in-vitro only?

The published research on this compound is cell-culture work. It is supplied for laboratory in-vitro study only, with no human-use framing.

Is it a p53 peptide?

It incorporates a p53-derived HDM-2-binding region joined to a membrane-penetrating leader, so it is often described in relation to the p53/HDM-2 axis.

What PNC-27 is studied for

HDM-2 cell-surface targeting

Studied for binding HDM-2 displayed on the surface of certain cancer cells in vitro.

Membrane pore formation

Examined for forming transmembrane pores that lead to lysis of targeted cells in culture.

Selectivity in vitro

Investigated for a reported preference for tumour cells over normal cells in preclinical cell-culture models.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More PNC-27 reference

FAQ reference for other compounds

PNC-27 overview PNC-27 calculatorPNC-27 product details

PNC-27 is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.